VRTX and CRNX Related Headlines
Go Back- Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
- Stifel Downgrades Crinetics (CRNX) to Hold
- Jones Trading Downgrades Crinetics (CRNX) to Hold
- Vertex (VRTX) Reiterated at Overweight by Cantor Fitzgerald; Crinetics Acquisition Announced
- Crinetics soars on $10B acquisition by Vertex
- Vertex to acquire Crinetics Pharmaceuticals for $10 billion
- Vertex to Acquire Crinetics Pharmaceuticals
VRTX and CRNX Related Press Releases
Go Back- Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
- Vertex to Acquire Crinetics Pharmaceuticals
